MARY BUCHHOLZ — Lobbyist Profile | Poliscope

MARY BUCHHOLZ

Reported covered position: N/A

Filings

Clients

Firms

Years active

2000–2005

Associated filing income

$2,660,500

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
OFFICE OF LIAISON COUNSEL - MDL 926	9	2001–2005
CFIDS ASSOCIATION OF AMERICA	8	2000–2004
AMERICAN CANCER SOCIETY	6	2001–2005
INTL MYELOMA FOUNDATION	5	2002–2004
CRUETZFELDT-JAKOB DISEASE FOUNDATION	3	2004
FENTON COMMUNICATIONS	3	2000–2004

Firm	Filings	Years
THE SHERIDAN GROUP	41	2000–2005

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

A bill to postpone the 2005 round of defense base closure and realignment.

Cited source text

HR 1323 Bills to promote research to identify and evaluate the health effects of silicone breast implants. S. 1075

A bill to postpone the 2005 round of defense base closure and realignment.

Cited source text

HR 1323; BILL TO PROMOTE RESEARCH TO IDENTIFY AND EVALUATE THE HEALTH EFFECTS OF SILICONE BREAST IMPLANTS S.1075

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

2005 · year_end · YA

Firm income: $275,645Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

HR 1323; BILL TO PROMOTE RESEARCH TO IDENTIFY AND EVALUATE THE HEALTH EFFECTS OF SILICONE BREAST IMPLANTS S.1075

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

2005 · mid_year · MA

Firm income: $174,355Client expense: —